The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background: Symptoms of cognitive impairment such as poor concentration, memory loss and difficulty with decision making are prevalent in patients with depression, but currently are not specific targets for treatment. However, patients can continue to demonstrate cognitive impairments even when apparently clinically recovered. Drugs that potentiate serotonin (5-HT) function, such as selective serotonin reuptake inhibitors (SSRIs), are the mainstay of treatment for depression. Nevertheless, our understanding of the effects of SSRIs and other conventional antidepressant therapy on cognitive function in healthy humans and depressed patients remains limited. Objective: The purpose of this article is to provide a concise overview for clinicians on the impact of pharmacological manipulation of 5-HT on cognitive function in healthy humans with additional reference to animal models where human data are lacking, particularly regarding specific 5-HT receptor subtype modulation. Findings: The most consistent observation following manipulation of serotonin levels in humans is that low extracellular 5-HT levels are associated with impaired memory consolidation. Preclinical data show that agonism and antagonism at specific 5-HT receptors can exert effects in animal models of cognition. Conclusions: Larger, consistently designed studies are needed to understand the roles of 5-HT in cognition in healthy and depressed individuals. Efforts to target specific 5-HT receptors to improve cognitive outcomes are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“These clinical findings should be considered in the context of animal studies showing that SSRI treatment, for example, facilitates neuroplasticity and neurogenesis in the hippocampus (Malberg et al., 2000; Santarelli et al., 2003).”
BackgroundChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“For example, in a meta-review and meta-regression of case control and cohort studies, Ownby et al. (2006) found that a history of depression produced a twofold increase in risk for subsequent development of Alzheimer’s disease.”
MethodMillan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
A meta-analysis of depression severity and cognitive function
McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956
McKinnon, M. C., Yucel, K., Nazarov, A., & MacQueen, G. M. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0905 · Cited by 742
Bang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101459g · Cited by 606 · cited 1×
“…for treatment of adults with MDD. Preclinical data show that vortioxetine functions as a 5-HT3, 5-HT7, and 5-HT1D receptor antagonist, a 5-HT1A receptor agonist, a 5-HT1B receptor partial agonist, and an inhibitor of the 5-HT transporter in vitro (Bang-Andersen et al., 2011; Westrich et al., 2012).”
BackgroundNeurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · cited 1×
“placebo and atomoxetine (Chamberlain et al., 2006) (N = 60 males) Acute (1.”
BackgroundSantana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486
Neurocognitive deficits and disability in major depressive disorder
Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.11.011 · Cited by 484
Research works printed but not linked: 64
- 10.1016/j.schres.2008.08.004 · DOI
- Albert PR, 2010, Front Neurosci, 4, 35
- 10.1097/00019442-200301000-00007 · DOI · Paper page
- 10.1007/s00213-012-2644-x · DOI
- 10.1016/j.eurpsy.2009.05.010 · DOI
- 10.1371/journal.pone.0020210 · DOI · Paper page
- Borkowska A, 2007, Neuropsychopharmacol Hung, 9, 131
- 10.1038/sj.bjp.0705800 · DOI · Paper page
- 10.1177/0269881107068066 · DOI · Paper page
- 10.1016/j.pnpbp.2010.11.006 · DOI
- 10.1016/j.coph.2011.01.004 · DOI
- 10.1111/j.1471-4159.2007.04768.x · DOI · Paper page
- 10.1016/S0006-3223(99)00014-1 · DOI · Paper page
- 10.1016/j.euroneuro.2010.04.005 · DOI
- 10.1007/s00213-009-1649-6 · DOI
- 10.1002/hup.1141 · DOI · Paper page
- 10.1097/00062752-200205000-00007 · DOI
- 10.1007/s00213-009-1693-2 · DOI
- 10.1016/S0304-3940(97)00451-5 · DOI
- 10.1037/a0029301 · DOI · Paper page
- 10.1017/S1355617710001566 · DOI · Paper page
- 10.1016/j.psychres.2007.04.012 · DOI · Paper page
- 10.1007/BF02249414 · DOI
- 10.1017/S1041610210000049 · DOI
- 10.1100/tsw.2010.180 · DOI
- 10.1016/j.tips.2008.07.001 · DOI · Paper page
- 10.1002/1097-0142(20001015)89:8<1739::AID-CNCR14>3.0.CO;2-F · doi:10.1002/1097-0142(20001015)89:8<1739::aid-cncr14>3.0.co;2-f
- 10.1016/j.jad.2011.10.023 · DOI · Paper page
- 10.1016/j.brainresbull.2003.09.022 · DOI
- 10.1111/j.1365-2125.2011.03902.x · DOI
- 10.1016/j.jad.2011.04.041 · DOI · Paper page
- 10.1016/j.biopsych.2009.10.006 · DOI · Paper page
- 10.1016/j.neuropharm.2004.06.033 · DOI
- McKinnon MC, 2009, J Psychiatry Neurosci, 34, 41
- 10.1016/j.neubiorev.2009.03.006 · DOI · Paper page
- 10.1016/j.bbr.2007.06.026 · DOI
- 10.1097/00004714-199806000-00006 · DOI · Paper page
- 10.1002/hup.970 · DOI
- 10.1101/lm.67303 · DOI · Paper page
- 10.1177/0269881105048887 · DOI · Paper page
- 10.1007/s00213-003-1683-8 · DOI · Paper page
- 10.1021/jm801327q · DOI
- 10.1177/026988110201600303 · DOI · Paper page
- 10.1002/hbm.20702 · DOI · Paper page
- 10.1186/1471-244X-10-47 · DOI
- 10.1007/s00213-003-1448-4 · DOI
- 10.1055/s-2008-1076724 · DOI
- 10.1016/j.neuropharm.2006.07.024 · DOI
- 10.1017/S1461145709990897 · DOI
- 10.1016/j.pnpbp.2011.03.004 · DOI
- 10.1097/00004714-200006000-00019 · doi:10.1097/00004714-200006000-00019
- 10.1016/S0006-3223(00)01025-8 · DOI
- 10.1016/j.schres.2007.06.008 · DOI
- 10.1002/hup.1105 · DOI
- 10.1007/s00213-004-2114-1 · DOI
- 10.1007/s002130050529 · DOI
- 10.1097/00001756-199612200-00011 · DOI
- Wagner S, 2012, Eur Psychiatry, 1, 1
- 10.1016/j.pharmthera.2010.07.001 · DOI · Paper page
- 10.1016/S0166-4328(96)00154-4 · DOI
- Westrich L, 2012, Int J Psychiatry Clin Pract, 16, 47
- 10.1007/s00213-006-0614-x · DOI
- 10.1002/hup.800 · DOI · Paper page
- 10.1016/j.acn.2007.12.005 · DOI
Cited by
Jenkins, T., Nguyen, J., Polglaze, K., & Bertrand, P. (2016) · Nutrients · doi:10.3390/nu8010056 · Cited by 904
“Tryptophan depletion studies have also been performed in clinical and preclinical studies to assess the relationship between a lowered serotonin system and cognition [30].”
BackgroundThe Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., & Joghataei, M. T. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 366
Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin
Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2015) · Human Brain Mapping · doi:10.1002/hbm.22833 · Cited by 339
“Indolealkylamines are relatives of 5-hydroxytryptamine (5-HT, also known as serotonin), an endogenous neuromodulator that plays a crucial role in the regulation of mood, sleep and cognition [Canli and Lesch, 2007; Cowen and Sherwood, 2013; Monti et al., 2008].”
BackgroundMicrobial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208
“Reductions in serotonin, therefore, are frequently linked with declines in learning, memory consolidation [226] and long-term memory [227].”
BackgroundDale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114543719 · Cited by 93
Metadata
- Authors
- Cowen, P., & Sherwood, A. C.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-03-27
- Volume
- 27
- Issue
- 7
- Pages
- 575-583
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2041613788
- Cited by
- 122
- References
- 30
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression. https://app.cochat.ai/papers/10.1177/0269881113482531
- The paper
- Cowen, P., & Sherwood, A. C. (2013). The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression. Journal of Psychopharmacology. https://doi.org/10.1177/0269881113482531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.